472 related articles for article (PubMed ID: 28644156)
1. Clinical Case of the Month: A 57-Year-Old Man with an Axillary Mass.
Desai P; Myers A; Boulmay B; Lopez FA
J La State Med Soc; 2017; 169(3):78-82. PubMed ID: 28644156
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade.
Gambichler T; Strutzmann S; Tannapfel A; Susok L
BMC Cancer; 2017 May; 17(1):327. PubMed ID: 28499411
[TBL] [Abstract][Full Text] [Related]
3. Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.
Gibney GT; Atkins MB
J Clin Oncol; 2015 Jun; 33(17):1873-7. PubMed ID: 25964248
[TBL] [Abstract][Full Text] [Related]
4. Metastatic uveal melanoma showing durable response to anti-CTLA-4 and anti-PD-1 combination therapy after experiencing progression on anti-PD-1 therapy alone.
Afzal MZ; Mabaera R; Shirai K
J Immunother Cancer; 2018 Feb; 6(1):13. PubMed ID: 29433557
[TBL] [Abstract][Full Text] [Related]
5. Pigmentation of axillary sentinel nodes from extensive skin tattoo mimics metastatic melanoma: case report.
Manganoni AM; Sereni E; Pata G; Ungari M; Pavoni L; Farisoglio C; Calzavara-Pinton PG; Farfaglia R
Int J Dermatol; 2014 Jun; 53(6):773-6. PubMed ID: 24372317
[TBL] [Abstract][Full Text] [Related]
6. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
7. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
Porter K; Rosenzweig MQ
J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
[No Abstract] [Full Text] [Related]
8. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
9. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
Silva NN; Eng C
J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
[TBL] [Abstract][Full Text] [Related]
10. Metastatic melanoma from an unknown primary site presenting as skin-colored nodules and multiple visceral involvement.
Ghosh SK; Bandyopadhyay D; Barma KD; Basu S; Roy A
Skinmed; 2012; 10(6):396-9. PubMed ID: 23346671
[TBL] [Abstract][Full Text] [Related]
11. Clinical case of the month. A 29-year-old man with acute onset blurry vision, weakness, and gait abnormality. Stroke.
Thoppil D; Ali MJ; Jain N; Kamboj S; Subramaniam P; Lopez FA
J La State Med Soc; 2009; 161(6):308-10, 312. PubMed ID: 20108823
[TBL] [Abstract][Full Text] [Related]
12. [(Neurological CPC-59). A 65-year-old man with a history of gastric cancer who presented progressive loss of vision, memory loss and consciousness disturbance].
Nohara C; Matsumine H; Suzuki K; Saito A; Ohtaka M; Mori H; Suda K; Kondo T; Hayakawa M; Kanai J; Mizuno Y
No To Shinkei; 1997 Nov; 49(11):1041-51. PubMed ID: 9396038
[TBL] [Abstract][Full Text] [Related]
13. Serial pseudoprogression of metastatic malignant melanoma in a patient treated with nivolumab: a case report.
Ozaki Y; Shindoh J; Miura Y; Nakajima H; Oki R; Uchiyama M; Masuda J; Kinowaki K; Kondoh C; Tanabe Y; Tanaka T; Haruta S; Ueno M; Kitano S; Fujii T; Udagawa H; Takano T
BMC Cancer; 2017 Nov; 17(1):778. PubMed ID: 29162045
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccination mimicking lymph-node progression in a patient with melanoma: a case report.
Indini A; Costa S; Ierardi AM; Rijavec E; Passoni E; Grossi F
Melanoma Res; 2021 Oct; 31(5):490-493. PubMed ID: 34433198
[TBL] [Abstract][Full Text] [Related]
15. BRAF mutation-positive folliculotropic metastatic melanoma.
Brick KE; Halling KC; Khan YK; Peters MS
Am J Dermatopathol; 2013 Jul; 35(5):609-12. PubMed ID: 23715079
[TBL] [Abstract][Full Text] [Related]
16. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
17. [A case of malignant melanoma, axillary lymph node metastasis proved by fine needle aspiration biopsy cytology].
Shinozaki N; Hashimoto K; Yamaguchi A; Hukunaga M; Hosoya T; Uchida K; Ishikawa M; Sakurai K
Gan No Rinsho; 1987 Apr; 33(4):438-41. PubMed ID: 3573315
[TBL] [Abstract][Full Text] [Related]
18. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
Khushalani NI
J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
[TBL] [Abstract][Full Text] [Related]
19. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph nodes suspicious for breast cancer metastasis: sampling with US-guided 14-gauge core-needle biopsy--clinical experience in 100 patients.
Abe H; Schmidt RA; Kulkarni K; Sennett CA; Mueller JS; Newstead GM
Radiology; 2009 Jan; 250(1):41-9. PubMed ID: 18955508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
